Skip to main content

Table 4 Determinants of unfavorable treatment outcome at the end of follow-up among those who restarted treatment for HAART after treatment interruption (n = 3,922)

From: Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia

Variable

Sub-category

Hazard ratio, crude

P- value

Hazard ratio, adj

P-value

Age

<15

1

   

≥15

1.4

0.300

  

Gender

Female

1

 

1

 

Male

1.6

<0.001

1.6

<0.001

Baseline WHO Stage

I or II

1

 

1

 

III or IV

1.2

0.061

1.3

0.014

Baseline CD4

<100

1

   

100–349

0.8

0.049

0.9

0.138

≥350

0.8

0.112

0.8

0.178

Time to 1st interruption

<6 months

1

 

1

 

≥ 6 months

0.4

<0.001

0.3

<0.001

Time to 1st restart

< 6 months

1

 

1

 

≥ 6 months

0.3

<0.001

0.2

<0.001